SCHEMBL22720447

SCHEMBL22720447

CCOC(=O)C1CCN(C2CCN(C(=O)OC(C)(C)C)CC2)C1=O

nearest known ligand 0.51

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.51
FPR2 P25090 1/20 0.48
L3MBTL1 Q9Y468 1/20 0.44
GPR119 Q8TDV5 2/20 0.44
KMT2A Q03164 4/20 0.42
MEN1 O00255 3/20 0.42
TSHR P16473 2/20 0.42
ALDH1A1 P00352 2/20 0.42
MAPT P10636 2/20 0.41
KDM4E B2RXH2 1/20 0.41
THRB P10828 1/20 0.41
HPGD P15428 1/20 0.40
LMNA P02545 1/20 0.39
GAA P10253 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
RECQL P46063 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31257394 0.93 TP53 (0.44) TP53FPR2L3MBTL1GPR119KMT2A
SCHEMBL22720284 0.91 FPR2 (0.48) TP53FPR2L3MBTL1GPR119KMT2A
SCHEMBL24603693 0.86 FPR2 (0.53) TP53FPR2L3MBTL1GPR119KMT2A
SCHEMBL22724577 0.84 FPR2 (0.41) TP53FPR2GPR119KMT2AMEN1
SCHEMBL23000018 0.84 TP53 (0.47) TP53FPR2L3MBTL1GPR119KMT2A
SCHEMBL22720490 0.84 FPR2 (0.52) TP53FPR2GPR119KMT2AMAPT
SCHEMBL20015491 0.81 MEN1 (0.44) TP53GPR119KMT2AMEN1TSHR
SCHEMBL183757 0.81 MEN1 (0.44) TP53GPR119KMT2AMEN1TSHR
SCHEMBL652243 0.80 MEN1 (0.45) TP53GPR119KMT2AMEN1TSHR
SCHEMBL19073726 0.80 MEN1 (0.45) TP53GPR119KMT2AMEN1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118745176-A Nitrogen-containing heterocyclic derivative regulator, preparation method and application thereof 上海翰森生物医药科技有限公司 2024-10-08 CN disclosed
CN-118745177-A Nitrogen-containing heterocyclic derivative regulator, preparation method and application thereof 上海翰森生物医药科技有限公司 2024-10-08 CN disclosed
CN-113423703-B Nitrogen-containing heterocyclic derivative regulator, preparation method and application thereof 上海翰森生物医药科技有限公司 2024-08-02 CN disclosed
US-20220213100-A1 NITROGEN-CONTAINING HETEROCYCLIC DERIVATIVE REGULATOR, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF SHANGHAI HANSOH BIOMEDICAL CO., LTD. (CN) 2022-07-07 US disclosed
CN-113423703-A Nitrogen-containing heterocyclic derivative regulator, and preparation method and application thereof 上海翰森生物医药科技有限公司 2021-09-21 CN disclosed
WO-2020239077-A1 NITROGEN-CONTAINING HETEROCYCLIC DERIVATIVE REGULATOR, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF 上海翰森生物医药科技有限公司 2020-12-03 WO disclosed
WO-2020239077-A1 NITROGEN-CONTAINING HETEROCYCLIC DERIVATIVE REGULATOR, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF 上海翰森生物医药科技有限公司 2020-12-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220213100-A1 NITROGEN-CONTAINING HETEROCYCLIC DERIVATIVE REGULATOR, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF KRAS, NRAS, GNAQ TP53 14/4885FPR2 3201/4885L3MBTL1 1842/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.